
Deepak Fertilisers & Petrochemicals Corp Ltd Q2 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- Mining Chemicals demand expected to grow 10-12% CAGR over next 5-6 years driven by coal mining, power, and infrastructure sectors.
- Current India demand for Technical Ammonium Nitrate (TAN) around 1.5-1.6 million tons expected to grow to 2.2-2.3 million tons, driven by infrastructure and mining growth.
- Capacity expansions (e.g., 50 KTPA de-bottlenecking recently done) to support volume growth and meet customer demand.
- Specialty fertilizers like Croptek showed 70% YoY growth; Rabi season prospects robust due to above-normal monsoon.
- Industrial Chemicals may see volume growth in specialty grades (steel grade nitric acid, pharma-grade IPA), with IPA volumes expected to improve post anti-dumping duty on imports.
- Mining Services division executing multiple projects, indicating growth trajectory.
- Overall company targeting sustained revenue growth through specialty products, backward integration benefits, and expansion projects operational by FY26-FY27.
See what Deepak Fertilisers & Petrochemicals Corp Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
YesSee what Deepak Fertilisers & Petrochemicals Corp Ltd management said on order book — free account, 30 seconds.
Capex plans
Yes- Deepak Fertilizers has an ongoing fast-paced CAPEX plan focusing on two key projects: the technical ammonium nitrate project at Gopalpur and the nitric acid project at Dahej.
- These projects are backed by 40 years of operating experience and target markets where the company already has a presence.
- Expected total CAPEX drawdowns are around Rs. 300-400 crores additional in the current fiscal year, with a total project CAPEX around Rs. 3,000 crores.
- About 30% of this CAPEX will be funded by equity; the balance through debt, with peak debt expected near Rs. 6,000 crores by end FY25-26 or early FY26-27.
- The CAPEX plans are considered risk-mitigated due to experience, existing market presence, and stable demand drivers aligned with India's growth story.
- Expansion in Mining Chemicals includes a recent 50 KTP capacity enhancement to meet growing demand.
Track Deepak Fertilisers & Petrochemicals Corp Ltd — get its next earnings analysis in your feed
How does Deepak Fertilisers & Petrochemicals Corp Ltd rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Deepak Fertilisers & Petrochemicals Corp Ltd rank in Chemicals & Petrochemicals?
Compare Deepak Fertilisers & Petrochemicals Corp Ltd against every Chemicals & Petrochemicals company (Q2 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Deepak Fertilisers & Petrochemicals Corp Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- GOCL Corporation Ltd (Q2 FY27)
Year-on-year (YoY) increase in revenue from operations: Approximately 85% increase (41,063 vs. Key results statement takeaways from GOCL Corpn.'s Q2 FY27 result
- AksharChem (I) (Q2 FY27)
Year-on-year revenue growth for the quarter is approximately 79.7% [(16,048.24 . Key results statement takeaways from AksharChem (I)'s Q2 FY27 results statement
- Bhansali Engineering Polymers Ltd (Q2 FY27)
Revenue from operations (net) for the quarter ended 30/09/2026 is ₹40,336.95 lakhs, compared to ₹32,509.76 lakhs for the quarter ended 30/09/2025, reflecting a…
- Tatva Chintan (Q2 FY27)
Q2 FY27 revenue from operations: ₹2,173 Mn, up 76% YoY from ₹1,235 Mn in Q2 FY26 (Page 11). Key investor presentation takeaways from Tatva Chintan's Q2 FY27 inv